-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
SOLUTIONS
-
Research & Development
-
Real World Evidence
-
Commercialization
-
Safety & Regulatory Compliance
-
Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
- Information Partner Services
- Financial Institutions
- Public Health and Government
- Patient Associations
- Payers
- Providers
THERAPEUTIC AREAS
- Cardiovascular
- Cell and Gene Therapy
- Central Nervous System
- GI & Hepatology
- Infectious Diseases and Vaccines
- Oncology
- Pediatrics
- Rare Diseases
- View All
Impacting People's Lives
"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MORE
Harness the power to transform clinical development
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewResearch & Development Quick Links
Real World Evidence. Real Confidence. Real Results.
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWReal World Evidence Quick Links
See markets more clearly. Opportunities more often.
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWCommercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWSafety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWTechnology Quick Links
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
BLOGS, WHITE PAPERS & CASE STUDIES
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSTHE IQVIA INSTITUTE
An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTS
FEATURED INNOVATIONS
-
IQVIA Connected Intelligence™
-
IQVIA Healthcare-grade AI™
-
Human Data Science Cloud
-
IQVIA Innovation Hub
-
Decentralized Trials
-
Patient Experience powered by Apple
WHO WE ARE
- Our Story
- Our Impact
- Commitment to Public Health
- Code of Conduct
- Environmental Social Governance
- Privacy
- Executive Team
NEWS & RESOURCES
Unlock your potential to drive healthcare forward
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
IQVIA AI is Healthcare-grade AI
Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MORE
Your healthcare data deserves more than just a cloud.
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
Proven, faster DCT solutions
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
IQVIA Patient Experience Solutions powered by Apple
Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm. IQVIA and Apple are collaborating to bring this exciting future of personalized care directly to devices patients already have and use.
LEARN MOREWORKING AT IQVIA
Our mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.
LEARN MORELIFE AT IQVIA
Careers, culture and everything in between. Find out what’s going on right here, right now.
LEARN MORE
WE’RE HIRING
"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
SEARCH JOBSPresentación
Análisis del mercado farmacéutico con efecto del COVID-19 - Semana 22
Jun 10, 2020
Durante la semana 22 se observa que tanto el mercado farmacéutico como el de Consumer Health mantienen la tendencia negativa de las últimas semanas de mayo. Ambos mercados presentan crecimientos positivos desde que empezó el año y desde la crisis sanitaria, pero debemos seguir de cerca la evolución en la próximas semanas de cara a evaluar si el mercado se normaliza en términos de crecimiento una vez entramos en el mes de Junio. Adjuntamos un breve resumen de los puntos más importantes a tener en cuenta:
- La actividad en la farmacia ha bajado ligeramente esta semana si nos fijamos en el número medio de tickets, concretamente un -4% respecto a la semana anterior, y un -10% con respecto a la misma semana de 2019.
- Aunque el mercado de prescripción en valores se mantiene creciendo en el acumulado desde la semana 6 a la 22 con respecto al mismo periodo del año pasado un 2,2%, lleva 6 semanas seguidas por debajo de niveles de 2019 (-5,4% w22 2020 vs 2019), siendo una semana más las clases relacionadas con el aparato respiratorio y sistema locomotor las que están conduciendo este decrecimiento.
- Todos los segmentos Consumer Health presentan crecimientos en valores en el mismo periodo acumulado de 2020 respecto 2019, salvo nutrición infantil, que lleva semanas presentando decrecimientos alrededor de -4%, y PEC dermocosmética, que esta semana se suma a los segmentos con balance negativo en el periodo acumulado aunque este decrecimiento es tan solo de -1,3%. Sin embargo, una vez más, los valores de mayo 2020 se sitúan por debajo de los de mayo 2019. En particular esta semana, los segmentos que más decrecen en valores respecto a la misma semana del año pasado son OTC, PEC y de nuevo, NUT infantil.
- El Mercado Covid-19 ha decrecido nuevamente esta semana y por primera vez se sitúa ligeramente por debajo de los niveles de 2019, presentando un decrecimiento de un -4,0% con respecto a la misma semana del año pasado. Este decrecimiento es conducido por todas las categorías salvo prevención higiene (mascarillas, guantes y geles hidroalcóholicos). Sin embargo, si atendemos al acumulado desde la semana 6, todos los segmentos que conforman este mercado presentan crecimientos a doble dígito, salvo prevención higiene que crece un 1.050%.
- El canal online se mantiene una semana más creciendo a triple dígito, un 201% en la w22 2020 con respecto a la misma semana del año anterior, si bien llevamos viendo decrecimientos semana a semana durante las últimas tres semanas (-20% w22 2020 vs. w21 2020).